Federated Hermes’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,349
| Closed | -$263K | – | 2147 |
|
|
2024
Q4 | $263K | Sell |
7,349
-1
| -0% | -$36 | ﹤0.01% | 1444 |
|
|
2024
Q3 | $347K | Sell |
7,350
-70
| -0.9% | -$3.31K | ﹤0.01% | 1400 |
|
|
2024
Q2 | $373K | Buy |
7,420
+7,413
| +105,900% | +$373K | ﹤0.01% | 1376 |
|
|
2024
Q1 | $788 | Buy |
+7
| New | +$788 | ﹤0.01% | 1967 |
|
|
2023
Q4 | – | Sell |
-56
| Closed | -$1.77K | – | 2140 |
|
|
2023
Q3 | $1.77K | Sell |
56
-5,570
| -99% | -$176K | ﹤0.01% | 1980 |
|
|
2023
Q2 | $463K | Buy |
+5,626
| New | +$463K | ﹤0.01% | 1398 |
|
|
2022
Q2 | – | Sell |
-28,957
| Closed | -$2.89M | – | 2235 |
|
|
2022
Q1 | $2.89M | Buy |
28,957
+20,854
| +257% | +$2.08M | 0.01% | 927 |
|
|
2021
Q4 | $1.26M | Buy |
+8,103
| New | +$1.26M | ﹤0.01% | 1194 |
|
|
2021
Q1 | – | Sell |
-7
| Closed | -$5K | – | 2309 |
|
|
2020
Q4 | $5K | Sell |
7
-11,134
| -100% | -$7.95M | ﹤0.01% | 2055 |
|
|
2020
Q3 | $5.19M | Buy |
11,141
+6,589
| +145% | +$3.07M | 0.01% | 720 |
|
|
2020
Q2 | $2.66M | Buy |
4,552
+2,024
| +80% | +$1.18M | 0.01% | 886 |
|
|
2020
Q1 | $369K | Buy |
+2,528
| New | +$369K | ﹤0.01% | 1461 |
|
|
2019
Q4 | – | Sell |
-2
| Closed | -$1K | – | 2120 |
|
|
2019
Q3 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 2117 |
|